BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 15525826)

  • 1. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases.
    Haddad R; Ogilvie RT; Croitoru M; Muniz V; Gryfe R; Pollet A; Shanmugathasan P; Fitzgerald T; Law CH; Hanna SS; Jothy S; Redston M; Gallinger S; Smith AJ
    Ann Surg Oncol; 2004 Nov; 11(11):977-82. PubMed ID: 15525826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive relevance of microsatellite instability in colorectal cancer.
    Storojeva I; Boulay JL; Heinimann K; Ballabeni P; Terracciano L; Laffer U; Mild G; Herrmann R; Rochlitz C
    Oncol Rep; 2005 Jul; 14(1):241-9. PubMed ID: 15944796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microsatellite instability of sporadic colorectal carcinomas and its clinicopathological significance].
    Xiao XY; Zhou XY; Sun MH; Yan G; Du X
    Zhonghua Zhong Liu Za Zhi; 2006 Apr; 28(4):289-93. PubMed ID: 16875631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer.
    Wright CM; Dent OF; Barker M; Newland RC; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
    Br J Surg; 2000 Sep; 87(9):1197-202. PubMed ID: 10971428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability and DNA ploidy in colorectal cancer: potential implications for patients undergoing systematic surveillance after resection.
    Søreide K; Slewa A; Stokkeland PJ; van Diermen B; Janssen EA; Søreide JA; Baak JP; Kørner H
    Cancer; 2009 Jan; 115(2):271-82. PubMed ID: 19109816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
    Messick CA; Church JM; Liu X; Ting AH; Kalady MF
    Ann Surg Oncol; 2010 Feb; 17(2):425-31. PubMed ID: 19885699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation, apoptosis, and survival in high-level microsatellite instability sporadic colorectal cancer.
    Michael-Robinson JM; Reid LE; Purdie DM; Biemer-Hüttmann AE; Walsh MD; Pandeya N; Simms LA; Young JP; Leggett BA; Jass JR; Radford-Smith GL
    Clin Cancer Res; 2001 Aug; 7(8):2347-56. PubMed ID: 11489812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers.
    Yang P; Cunningham JM; Halling KC; Lesnick TG; Burgart LJ; Wiegert EM; Christensen ER; Lindor NM; Katzmann JA; Thibodeau SN
    Mol Genet Metab; 2000 Dec; 71(4):639-45. PubMed ID: 11136557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
    Elsaleh H; Iacopetta B
    Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival.
    Choi SW; Lee KJ; Bae YA; Min KO; Kwon MS; Kim KM; Rhyu MG
    Clin Cancer Res; 2002 Jul; 8(7):2311-22. PubMed ID: 12114436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite and chromosomal stable colorectal cancers demonstrate poor immunogenicity and early disease recurrence.
    Banerjea A; Hands RE; Powar MP; Bustin SA; Dorudi S
    Colorectal Dis; 2009 Jul; 11(6):601-8. PubMed ID: 18637931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.
    Elsaleh H; Powell B; McCaul K; Grieu F; Grant R; Joseph D; Iacopetta B
    Clin Cancer Res; 2001 May; 7(5):1343-9. PubMed ID: 11350904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of microsatellite instability in resectable pancreatic cancer.
    Nakata B; Wang YQ; Yashiro M; Nishioka N; Tanaka H; Ohira M; Ishikawa T; Nishino H; Hirakawa K
    Clin Cancer Res; 2002 Aug; 8(8):2536-40. PubMed ID: 12171881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection.
    Yang Y; Forslund A; Remotti H; Lönnroth C; Andersson M; Brevinge H; Svanberg E; Lindnér P; Hafström L; Naredi P; Lundholm K
    Cancer; 2001 Feb; 91(4):727-36. PubMed ID: 11241240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective analysis of microsatellite instability as a molecular marker in colorectal cancer.
    Chang EY; Dorsey PB; Johnson N; Lee R; Walts D; Johnson W; Anadiotis G; Kiser K; Frankhouse J
    Am J Surg; 2006 May; 191(5):646-51. PubMed ID: 16647353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low microsatellite instability is associated with poor prognosis in stage C colon cancer.
    Kohonen-Corish MR; Daniel JJ; Chan C; Lin BP; Kwun SY; Dent OF; Dhillon VS; Trent RJ; Chapuis PH; Bokey EL
    J Clin Oncol; 2005 Apr; 23(10):2318-24. PubMed ID: 15800322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews.
    Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N
    J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability did not predict individual survival in sporadic stage II and III rectal cancer patients.
    Meng WJ; Sun XF; Tian C; Wang L; Yu YY; Zhou B; Gu J; Xia QJ; Li Y; Wang R; Zheng XL; Zhou ZG
    Oncology; 2007; 72(1-2):82-8. PubMed ID: 18004081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is MSI-H of value in predicting the development of metachronous colorectal cancer?
    Lawes DA; Pearson T; Sengupta S; Boulos PB
    Eur J Cancer; 2006 Mar; 42(4):473-6. PubMed ID: 16427780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.